AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
NexMed receives patent allowance for Femprox.
2002 JUN 20 - (NewsRx.com & NewsRx.net) -- NexMed, Inc., (NEXM) has received a notice of allowance for its U.S. patent application entitled "Compositions and Methods for Amelioration of Human Female Sexual Dysfunction".
The patent application covers the formulation and administration of Femprox, NexMed's topical cream for treating female sexual arousal disorder (FSAD). Femprox incorporates alprostadil, a vasodilator, with the NexACT platform drug delivery technology.
Dr. James Yeager, senior vice president for scientific affairs commented, "The U.S. Patent and Trademark Office has stated that the claimed invention is deemed allowable over the prior art. We are very pleased with its decision to allow all of our pending claims for Femprox, which are supported by disclosed clinical data." ...
- Femprox Demonstrated Positive Results in Female Sexual Arousal Disorder Study.
- Press release article from: Business Wire December 1, 1999 700+ words
...announced today that its Femprox cream, incorporating...E1), for treating female sexual arousal disorder...sexual stimulation. The Femprox cream is a promising...in the Management of Female Sexual Dysfunction. He commented...results indicate that the Femprox cream may also ...
- NexMed Presents Clinical Data On Femprox for Treating Female Sexual...
- Press release article from: Business Wire October 20, 1999 700+ words
...clinical data on the Femprox topical treatment for female sexual dysfunction ("FSD...Alprox-TD and Femprox, topically-applied...treatments for male and female sexual dysfunction; and...herpes. Alprox-TD, Femprox, NexACT and Viratrol...
- NexMed to Initiate 400 Femprox(R) Clinical Study in China For Female Sexual...
- Press release article from: PR Newswire March 2, 2004 700+ words
...400-patient Phase 3 study for Femprox(R) in China. The design of...test the efficacy and safety of Femprox(R) cream in patients diagnosed with female sexual arousal disorder (FSAD). Femprox(R), recently profiled on CBS...
- NexMed Announces Positive Femprox Study Results at AUA Annual Meeting in San...
- Press release article from: PR Newswire May 23, 2005 700+ words
...strengths of the Femprox(R) cream in...diagnosed with female sexual arousal disorder ("FSAD"). Femprox is applied topically...development plans for Femprox are expected to...partner. About Female Sexual Arousal Disorder...
- NexMed Announces Femprox(R) License Agreement for South Korea; - Femprox(R) in...
- Press release article from: PR Newswire February 19, 2004 700+ words
...in South Korea, has licensed Femprox(R) for Korea. Femprox(R) is NexMed's proprietary cream treatment for female sexual arousal disorder ("FSAD...regulatory approval to market Femprox(R) in South Korea, and NexMed...
- NEXMED LICENSES FEMPROX TO CJ CORP. FOR SOUTH KOREA.
- Newspaper article from: Worldwide Biotech April 1, 2004 700+ words
...companies in South Korea, has licensed Femprox for Korea. Femprox is NexMed's proprietary cream treatment for female sexual arousal disorder (FSAD). Pursuant...obtain regulatory approval to market Femprox(r) in South Korea, and NexMed...
- Femprox Data Published in Journal of Sex and Marital Therapy.
- Press release article from: PR Newswire October 2, 2001 700+ words
...and Marital Therapy. Femprox(TM) is NexMed's...for the treatment of female sexual arousal disorder...clinical program for Femprox(TM), and initiated...in the Treatment of Female Sexual Arousal Disorder" evaluated...safety of three doses of Femprox(TM) cream in patients...
- NexMed Initiates 400 Patient Femprox(R) Study Overseas.
- Press release article from: PR Newswire June 28, 2004 700+ words
...efficacy and safety of Femprox(R) cream in women diagnosed with female sexual arousal disorder (FSAD). Femprox(R) is topically...Amelioration of Human Female Sexual Dysfunction," which...patent covering Femprox(R) and provide...
Source: HighBeam Research, NexMed receives patent allowance for Femprox.